Brief: Dr. Lal Pathlabs March Quarter Consol Net Profit Jumps
21/05/2021 15:05
May 21 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* RECOMMENDED FINAL DIVIDEND OF 8 RUPEES PER SHARE
* MARCH QUARTER CONSOL NET PROFIT 834 MILLION RUPEES VERSUS
PROFIT
325 MILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 4.31 BILLION
RUPEES
VERSUS 3.02 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE2npC9p
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise